Direct oral anticoagulant use in valvular heart disease
SL Anderson, JC Marrs - Clinical Medicine Insights …, 2018 - journals.sagepub.com
Direct oral anticoagulants (DOACs) are indicated by the European Medicines Agency and
US Food and Drug Administration for stroke prevention in patients with nonvalvular atrial …
US Food and Drug Administration for stroke prevention in patients with nonvalvular atrial …
Can direct oral anticoagulants be used for stroke prevention among patients with valvular atrial fibrillation?
SL Anderson, JC Marrs - Current Cardiology Reports, 2019 - Springer
Abstract Purpose of Review To review the clinical evidence underlying the efficacy and
safety of the use of direct oral anticoagulants (DOACs) for the treatment of patients with …
safety of the use of direct oral anticoagulants (DOACs) for the treatment of patients with …
Direct oral anticoagulant use in nonvalvular atrial fibrillation with valvular heart disease: a systematic review
RE Owens, R Kabra, CS Oliphant - Clinical Cardiology, 2017 - Wiley Online Library
Direct oral anticoagulants (DOACs) are indicated for stroke prevention in patients with
nonvalvular atrial fibrillation (NVAF), which, according to the American College of …
nonvalvular atrial fibrillation (NVAF), which, according to the American College of …
Evaluation of the safety and effectiveness of direct-acting oral anticoagulants in patients with atrial fibrillation and coexisting valvular heart disease
ML Hampton, KB Tellor, AL Armbruster… - American Journal of …, 2020 - Springer
Background Current guidelines recommend direct-acting oral anticoagulants (DOACs) over
warfarin in patients with atrial fibrillation (AF) and valvular heart disease (VHD) without a …
warfarin in patients with atrial fibrillation (AF) and valvular heart disease (VHD) without a …
Comparison of the direct oral anticoagulants and warfarin in patients with atrial fibrillation and valvular heart disease: updated systematic review and meta-analysis of …
YSL Bitar, AR Duraes, L Roever… - Frontiers in …, 2021 - frontiersin.org
Background: Direct oral anticoagulants (DOACS) are approved for use in non-valvular atrial
fibrillation (AF). This systematic review and meta-analysis aimed to evaluate the efficacy and …
fibrillation (AF). This systematic review and meta-analysis aimed to evaluate the efficacy and …
Direct oral anticoagulants in patients with atrial fibrillation and valvular heart disease other than significant mitral stenosis and mechanical valves: a meta-analysis
Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Disease Other
Than Significant Mitral Stenosis and Mechanical Valves | Circulation Science Volunteer Warning …
Than Significant Mitral Stenosis and Mechanical Valves | Circulation Science Volunteer Warning …
Off-label use for direct oral anticoagulants: valvular atrial fibrillation, heart failure, left ventricular thrombus, superficial vein thrombosis, pulmonary hypertension—a …
H Brokmeier, K Kido - Annals of Pharmacotherapy, 2021 - journals.sagepub.com
Objective: To evaluate clinical literature for direct oral anticoagulants (DOACs) therapy for
non–Food and Drug Administration approved indications. Data Sources: Articles from …
non–Food and Drug Administration approved indications. Data Sources: Articles from …
Direct Oral anticoagulants for stroke prevention in special populations: beyond the clinical trials
A Carbone, R Bottino, A D'Andrea, V Russo - Biomedicines, 2023 - mdpi.com
Currently, direct oral anticoagulants (DOACs) are the first-line anticoagulant strategy in
patients with non-valvular atrial fibrillation (NVAF). They are characterized by a more …
patients with non-valvular atrial fibrillation (NVAF). They are characterized by a more …
Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Significant Mitral Stenosis—a Preliminary Meta-Analysis
Y Zhang, M Chen - Cardiovascular Drugs and Therapy, 2023 - Springer
Introduction Patients with atrial fibrillation (AF) and concomitant moderate-to-severe mitral
stenosis (MS) are listed as a contraindicated population to direct oral anticoagulant (DOAC) …
stenosis (MS) are listed as a contraindicated population to direct oral anticoagulant (DOAC) …
Oral anticoagulation for stroke prevention amongst atrial fibrillation patients with valvular heart disease: an update
Atrial fibrillation patients with concomitant valvulopathies constitute a group with high
thromboembolic risk and should be treated with oral anticoagulation. There is good …
thromboembolic risk and should be treated with oral anticoagulation. There is good …
相关搜索
- atrial fibrillation heart disease
- meta analysis heart disease
- oral anticoagulants heart disease
- oral anticoagulants stroke prevention
- oral anticoagulants atrial fibrillation
- mechanical valves heart disease
- stroke prevention heart disease
- oral anticoagulants evaluation of the safety
- warfarin in patients heart disease
- evaluation of the safety heart disease
- fibrillation patients heart disease
- oral anticoagulants safety and effectiveness
- safety and effectiveness heart disease